Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma - a nationwide population-based cohort study

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

  • Michael Roost Clausen
  • Sinna Pilgaard Ulrichsen
  • Thomas Stauffer Larsen, Department of Hematology and the Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, DK-5000, Odense C, Denmark.
  • ,
  • Christian B Poulsen, d Department of Hematology , Zealand University Hospital , Roskilde , Denmark.
  • ,
  • Selma Tojaga, e Department of Hematology , Sygehus Lillebaelt , Vejle , Denmark.
  • ,
  • Per Trøllund Pedersen, f Department of Hematology , Sydvestjysk Sygehus , Esbjerg , Denmark.
  • ,
  • Jakob Madsen, g Department of Hematology , Aalborg University Hospital , Aalborg , Denmark.
  • ,
  • Robert Schou Pedersen, h Department of Medicine , Hospitalsenheden Vest , Holstebro , Denmark.
  • ,
  • Pär Lars Josefsson, i Department of Hematology, Herlev Hospital , Herlev , Denmark.
  • ,
  • Jette Sønderskov Gørløv, j Department of Hematology , Rigshospitalet , Copenhagen , Denmark.
  • ,
  • Mette Nørgaard
  • ,
  • Francesco d'Amore

We investigated if survival was predicted by nadir neutrophil counts after the first cycle of R-CHOP in patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL). Neutrophil counts (109/L) were categorized in four grades in the nadir time frame. Prognostic indices and comorbidity levels were calculated and used to adjust the Cox regression model. Kaplan-Meier and Cox regression methods were used to estimate and compare survival. We identified 965 patients. Grade 4 neutropenia was present in 432 (45%). Grade 0 patients had a 5-year overall survival of 67%, grade 1-2: 78%, grade 3: 64%, and grade 4: 57%. Compared with grade 0 adjusted hazard ratios (HR) for death were: 0.77 (95% CI 0.49-1.21) for grade 1-2, 1.18 (95% CI 0.82-1.71) for grade 3, and 1.33 (95% CI 1.02-1.73) for grade 4. Grade 4 neutropenia after the 1st cycle of chemotherapy predicted inferior outcome compared with grade 0 and 1-2. Grade 1-2 neutropenia seemed to have superior outcome.

OriginalsprogEngelsk
TidsskriftLeukemia and Lymphoma
Vol/bind60
Nummer8
Sider (fra-til)1950-1957
Antal sider8
ISSN1042-8194
DOI
StatusUdgivet - aug. 2019

Se relationer på Aarhus Universitet Citationsformater

ID: 143392255